Literature DB >> 9973027

Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects.

C S Duvernoy1, C Meyer, V Seifert-Klauss, F Dayanikli, I Matsunari, J Rattenhuber, C Höss, H Graeff, M Schwaiger.   

Abstract

OBJECTIVES: The purpose of the study was to compare myocardial blood flow (MBF) in hyperlipidemic postmenopausal women and age-matched hyperlipidemic men, and to analyze the relationship between cholesterol subfractions and myocardial blood flow in men and women.
BACKGROUND: Women are protected from coronary artery disease (CAD) events until well after menopause, in part due to gender-specific differences in lipid profiles.
METHODS: To examine the effect of these influences on coronary microcirculation, MBF was quantitated with N-13 ammonia/PET (positron emission tomography) at rest and during adenosine hyperemia in 15 women and 15 men, all nondiabetic, who were matched for age and total cholesterol levels (53+/-4 vs. 50+/-8 years, p = NS, 6.44+/-1.1 vs. 6.31+/-0.85 mmol/liter, or 249+/-41 vs. 244+/-33 mg/dl, p = NS).
RESULTS: Women had significantly higher high density lipoprotein (HDL) and lower triglyceride (Tg) levels than did men, and they showed significantly higher resting MBF and stress MBF levels. Significant correlations were found between resting and hyperemic MBF and HDL and Tg levels (r = 0.44, p < 0.02 for stress MBF vs. HDL; r = 0.48, p < 0.007 for stress MBF vs. Tg). Gender was the strongest predictor of hyperemic MBF in multivariate analysis. Women responded to adenosine hyperemia with a significantly higher heart rate than did men, and hemodynamic factors correlated significantly with blood flow both at rest and during stress.
CONCLUSIONS: These data suggest that the favorable lipid profile seen in women may be associated with preserved maximal blood flow in the myocardium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973027     DOI: 10.1016/s0735-1097(98)00575-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  27 in total

1.  Myocardial blood flow: Putting it into clinical perspective.

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

2.  Insulin resistance is a major determinant of myocardial blood flow impairment in anginal patients.

Authors:  Riccardo Liga; Daniele Rovai; Tiziana Sampietro; Cecilia Vecoli; Giancarlo Todiere; Chiara Caselli; Giuseppe Rossi; Antonio L'abbate; Danilo Neglia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-11       Impact factor: 9.236

Review 3.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 4.  Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

Authors:  D Le Guludec; R Lautamäki; J Knuuti; J J Bax; F M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-26       Impact factor: 9.236

5.  Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction.

Authors:  Danilo Neglia; Tiziana Sampietro; Cecilia Vecoli; Riccardo Liga; Giuseppe Rossi; Elena Filidei; Federico Bigazzi; Patricia Iozzo; Daniela Giannessi; Antonio L'Abbate; Daniele Rovai
Journal:  J Nucl Cardiol       Date:  2012-08-10       Impact factor: 5.952

6.  Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.

Authors:  Felix Stader; Marco Siccardi; Manuel Battegay; Hannah Kinvig; Melissa A Penny; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2019-04       Impact factor: 6.447

7.  Sex difference in cardiac metabolism in nonischemic heart failure: Insight for prognostic value of altered cardiac metabolism.

Authors:  Hyung-Jun Im; Gi Jeong Cheon
Journal:  J Nucl Cardiol       Date:  2016-04-06       Impact factor: 5.952

8.  Optimal thallium-201 dose in cadmium-zinc-telluride SPECT myocardial perfusion imaging.

Authors:  Masaru Ishihara; Yasuyo Taniguchi; Masahisa Onoguchi; Takayuki Shibutani
Journal:  J Nucl Cardiol       Date:  2016-12-22       Impact factor: 5.952

9.  Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli; Andrew Einstein; Raymond Russell; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

10.  Impact of hormone replacement on myocardial fatty acid metabolism: potential role of estrogen.

Authors:  Pilar Herrero; Pablo F Soto; Carmen S Dence; Zulfia Kisrieva-Ware; Deborah A Delano; Linda R Peterson; Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2005 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.